CNS Disorders Therapeutics companies

A venture fund investing in early-stage psychedelic-based wellness, therapeutic and pharmaceutical companies globally.

Invested in breaking ‍through paralysis.

Palo Santo’s diversified investment fund is helping to increase the supply of clinically effective and accessible mental health and addiction treatment solution…

We build and invest in companies that transform healthcare.

4BIO Capital is an international venture capital firm focused solely on the advanced therapies sector.

A CHF 50M venture capital fund aimed at supporting the development of neuroenhancement technologies.

Cambrian Biopharma is building the medicines that will redefine healthcare in the 21st century – therapeutics to lengthen healthspan, the period of life spent i…

A £250m specialist venture capital fund that invests in, and creates, new biotech companies to deliver high impact therapeutics for age-related dementias.